Skip to main content
. 2012 Apr;56(4):1784–1796. doi: 10.1128/AAC.05869-11

Fig 3.

Fig 3

Structure-activity bioassay experiments characterizing the efficacy of VanJ. Paper discs containing approximately 30 μg/ml of each glycopeptide shown were placed on freshly spread lawns of a ΔvanRS indicator strain carrying the ermEp-vanJ overexpression plasmid pGN024 (+, strain H243) or only the empty vector (−, strain H102). Plates are shown after 2 days of incubation at 30°C.